| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1803466A1 Treatment of chronic joint inflammation by an anti-CD3 antibody |
| 07/04/2007 | EP1803458A1 Use of inorganic salts in the treatment of inflammation |
| 07/04/2007 | EP1803451A1 Pufa supplements |
| 07/04/2007 | EP1803358A1 Infant immunological formula |
| 07/04/2007 | EP1802656A1 Tweak receptor |
| 07/04/2007 | EP1534326B1 Improved bacterial outer membrane vesicles |
| 07/04/2007 | EP1478327A4 Method of reducing and treating uvb-induced immunosuppression |
| 07/04/2007 | EP1339349A4 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 07/04/2007 | EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions |
| 07/04/2007 | EP1124982B1 THE HEMATOPOIETIC, MYELOPROTECTING, ANTITUMOR IMMUNE CELLS GENERATING AND RADIOSENSITIZING POLYSACCHARIDE ISOLATED FROM i PANAX GINSENG /i |
| 07/04/2007 | EP1034301B1 Inhibition of an fgf-binding protein using ribozymes |
| 07/04/2007 | EP0958834B1 Use of peptide-based immunotherapeutic agent |
| 07/04/2007 | EP0942750B1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 07/04/2007 | EP0935660B1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
| 07/04/2007 | EP0567566B2 Methods for treating tumor necrosis factor mediated diseases |
| 07/04/2007 | CN1993469A Recombinant alpha-fetoprotein, method and means for preparation thereof, compositions on the base thereof and use thereof |
| 07/04/2007 | CN1993463A Follistatin mutant polypeptide |
| 07/04/2007 | CN1993346A Novel thiophene derivatives |
| 07/04/2007 | CN1993127A Azaindoles modulating c-kit activity and uses therefor |
| 07/04/2007 | CN1993118A Aqueous eye drops with accelerated intraocular migration permeability |
| 07/04/2007 | CN1993115A Compound formulations of 2-amino-1, 3-propanediol compounds |
| 07/04/2007 | CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor |
| 07/04/2007 | CN1990485A Silybin flavonolignan and their production method and use |
| 07/04/2007 | CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1989969A Cyclic protein tyrosine kinase inhibitors |
| 07/04/2007 | CN1989961A Use of non-steroidal sulfamate compound in the prepararion of drug for treating tumor |
| 07/04/2007 | CN1324034C Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics |
| 07/04/2007 | CN1324029C Amino biological pterin derivative and pharmaceutical use thereof |
| 07/04/2007 | CN1324025C Tropane derivatives as CCR5 modulators |
| 07/04/2007 | CN1324014C Pyridazin-3(2h)-one derivatives as PDE4 inhibitors |
| 07/04/2007 | CN1324012C TNF-alpha prodn. inhibitors |
| 07/04/2007 | CN1324006C Beta-amino acid nitrile derivs. |
| 07/04/2007 | CN1324004C New phenyl-naphthalene derivatives, and preparation method and drug containing same |
| 07/04/2007 | CN1323722C Positional isomers of PEG IFN alpha 2a |
| 07/04/2007 | CN1323672C Cell growth regulatory factor C and preparing process thereof |
| 07/04/2007 | CN1323671C Cell growth regulating factor J and its prepn process |
| 07/04/2007 | CN1323670C Cell growth regulatory factor L and preparing process thereof |
| 07/04/2007 | CN1323669C Cell growth regulating factor P and its prepn process |
| 07/04/2007 | CN1323668C Pharmaceutical compositions and its application |
| 07/03/2007 | US7238834 Piperidine derivatives and process for their production |
| 07/03/2007 | US7238812 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10 -dioxo-2H-1,2,3-triazolo(4,5-c)(1)benzazepine, for example; chemical intermediates, synthesis using relatively inexpensive reagents |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/03/2007 | US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 07/03/2007 | US7238703 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/03/2007 | US7238699 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238691 Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activity |
| 07/03/2007 | US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 07/03/2007 | US7238666 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/03/2007 | US7238658 Treating agonist disorders including obesity, and hyperglycemic, whole body growth, immunological, kidney, neurological and neuromuscular disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern |
| 07/03/2007 | US7238499 Trimeric macrophage scavenger receptor fusion proteins and encoding nucleic acids |
| 07/03/2007 | US7238481 administering HETEROLOGOUS GENE PRODUCTS IN HOST CELL SYSTEMS AND/OR TO RESCUE NEGATIVE STRAND RNA RECOMBINANT VIRUSES |
| 07/03/2007 | US7238360 Getting the same result as gene therapy, without the introduction of exogenous DNA, by binding T cell with immunomodulator biotin, then contacting with avidin or streptavidin; apoptosis induction or resistance |
| 07/03/2007 | US7238358 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/03/2007 | CA2361987C Goodpasture antigen binding protein |
| 07/03/2007 | CA2359177C Bhv-1 gene-deleted virus vaccine |
| 07/03/2007 | CA2350884C Topical compositions comprising ascomycins |
| 07/03/2007 | CA2252465C Urea derivatives as inhibitors of impdh enzyme |
| 07/03/2007 | CA2174122C Therapeutic delivery compositions and methods of use thereof |
| 06/29/2007 | CA2572057A1 A photoactive biocompatible coating composition |
| 06/28/2007 | WO2007073137A1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli |
| 06/28/2007 | WO2007073005A1 Regulator of methyl transfer reaction |
| 06/28/2007 | WO2007072977A1 Pharmaceutical composition for allergic disease |
| 06/28/2007 | WO2007072909A1 NOVEL OLIGONUCLEOTIDE AND NF-κB DECOY COMPRISING THE SAME |
| 06/28/2007 | WO2007072866A1 Anti-ilt7 antibody |
| 06/28/2007 | WO2007072100A1 Fagonia bruguieri freeze-dried extract as anti-allergic treatment |
| 06/28/2007 | WO2007071978A1 Method of producing rough strains of bacteria and uses thereof |
| 06/28/2007 | WO2007071839A2 Potentiation of apoptosis by monoclonal antibodies |
| 06/28/2007 | WO2007071691A1 3- (4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] 0xy} phenyl) -1-piperidinyl] carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders |
| 06/28/2007 | WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 06/28/2007 | WO2007071400A1 Pyrazine derivatives as epithelial sodium channel blocker |
| 06/28/2007 | WO2007071053A1 Markers for memory t cells and uses thereof |
| 06/28/2007 | WO2007070981A1 Compounds having cytokine modulating properties |
| 06/28/2007 | WO2007070961A1 Mif inhibitors |
| 06/28/2007 | WO2007053952B1 Platelet factor-4 (pf-4) analogs and their use |
| 06/28/2007 | WO2007051805A3 Use of ceacam8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 06/28/2007 | WO2007050607A3 Novel use of il-1beta compounds |
| 06/28/2007 | WO2007044756A3 Monoclonal antibodies recognizing human ccr8 |
| 06/28/2007 | WO2006060507A9 Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders |
| 06/28/2007 | US20070150971 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 06/28/2007 | US20070149619 Anti-aging agent |
| 06/28/2007 | US20070149563 N-(1-Azabicyclo[2.2.2]oct-3-yl)(2-(3-pyridyl)thiazole-4-carboxamide); nicotinic acetylcholine receptor ligands; psychotic and intellectual impairment disorders; antidepressant, anxiolytic agent; Alzheimer's disease, cognitive or attention disorders |
| 06/28/2007 | US20070149477 Stimulating a Th2 response by administering multivalent LNFPIII, an immunomodulatory glycan Lacto-N-Fucopentaose III, which contains the Lewis X trisaccharide (CD!%/antigen/); autoimmune disease; antidiabetic agents; antiarthritic agents; multiple sclerosis; colitis; psoriasis |
| 06/28/2007 | US20070148731 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 06/28/2007 | US20070148688 Novel human enzymes of the metalloprotease family |
| 06/28/2007 | US20070148686 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148254 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres |
| 06/28/2007 | US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 06/28/2007 | US20070148216 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic |
| 06/28/2007 | US20070148209 Allergic constitution ameliorator |
| 06/28/2007 | US20070148183 Chemically programmable immunity |
| 06/28/2007 | US20070148162 Molecule which binds cd80 and cd86 |
| 06/28/2007 | US20070148129 Therapeutic agents and uses therefor |
| 06/28/2007 | US20070148088 Cytotoxic therapy |